AstraZeneca partners with Oracle to bring AI into clinical trials

AstraZeneca partners with Oracle to bring AI into clinical trials
Credit stress is threatening to unwind the AI bull. All eyes are on Oracle to hold the line
Oracle trucks in natural gas to keep AI data centres on schedule as pipelines lag
Oracle (ORCL) Stock Slips 4.5% on $20 Billion OpenAI Revenue Gap
Oracle Gave Larry Ellison and His Co-CEOs Nearly $1 Billion in Stock Options. By Year End, Every Single One Was Underwater
Open USD Launches With $1 Billion in Backing and Chainlink as Its Data Oracle
382.45BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US68389X1054
CUSIP
68389X105
Sector
Technology
Industry
Software - Infrastructure
Fiscal Year End
May
IPO date
-
Updated At
-
PE Ratio
19.77
PEG Ratio
0.80
Book Value
20.44
Dividend Share
2
Dividend Yield
1.59%
Earnings Share
6.38
Wall Street Target Price
236.54
EPS Estimate Current Year
8.05
EPS Estimate Next Year
10.92
EPS Estimate Current Quarter
1.7383
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
71,776,002,048
Gross Profit TTM
45,906,001,920
EBITDA
34,432,999,424
Profit Margin
26.36%
Return On Assets TTM
6.36%
Return On Equity TTM
41.19%
Revenue Per Share TTM
24.793
Qtly Revenue Growth YOY
29.60%
Diluted Eps TTM
6.38
Qtly Earnings Growth YOY
54.50%
Trailing PE
19.77
Forward PE
17
Price Sales TTM
5.3284
Price Book MRQ
7.0025
Enterprise Value Revenue
7
Enterprise Value EBITDA
14
258.40
8.60%327.00
7.70%382.10
7.66%180.41
4.30%216.61
1.93%524.92
0.74%197.42
0.63%424.50
0.48%76.00
0.00%76.50
-3.19%Curated watchlists where ORCL is featured.